Remus Pharmaceuticals Limited Appoints Sharp & Tannan Associates as Internal Auditor for FY 2026-27
Remus Pharmaceuticals Limited announced that its Board of Directors, following the recommendation of the Audit Committee, appointed Sharp & Tannan Associates, Chartered Accountants, as the Internal Auditor for the Financial Year (FY) 2026-27. The decision was formalized during a Board meeting held on May 20, 2026.The appointment designates Sharp & Tannan Associates, whose firm registration number is 109983W, to conduct the Internal Audit of the Company for the specified financial year.
Auditor Details and Scope
The appointed firm, Sharp & Tannan Associates, specializes in internal audit, assurance, and consulting works. According to the details provided, the firm was established in 1934 by Mr. CR Sharp and Mr. BR Tannan. While the head office is located in Mumbai, S&TA maintains branches across India, including Ahmedabad and Baroda in Gujarat.The firm is currently supported by nine partners: Alkesh Hirapara, Amit Shah, Hemal Modi, Sapan Gandhi, Arnob Chaudhary, Hemul Desai, Parthiv Desai, Pramod Bhise, and Tirthraj Khot. These partners collectively bring an experience spanning more than six decades to the field.
In addition to its audit services, S&TA focuses on risk-based auditing and implementing a value-added approach to business processes. The firm is noted for conducting fair and unbiased category audits under the COSO 1992 framework, having been active for the past three decades. Their services cover risk identification, strategic input, operational control optimization, and compliance with relevant statutes and organizational policies.
The key details regarding the appointment are summarized below:
| Particulars | Detail |
|---|---|
| Internal Auditor | Sharp & Tannan Associates, Chartered Accountants |
| Firm Registration No. | 109983W |
| Date of Appointment | May 20, 2026 |
| Term of Appointment | Internal Audit for FY 2026-27 |
| Nature of Change | Appointment |
REMUS Stock Price Movement
Shares of Remus Pharmaceuticals Limited today slipped by 4.04% to settle at ₹855.25. The stock saw total traded volume reach 41,300 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.